Despite PD‐L1's typical high expression in tumors to aid in immune escape, our analysis of TCGA prostate cancer data surprisingly showed relatively low PD‐L1 expression in prostate cancer tissues, which significantly increases in castration‐resistant prostate tissues and cells. Here, CD274 is linked to prostate carcinoma.